https://www.selleckchem.com/pr....oducts/1-methyl-3-ni
Owing to concerns regarding adequate oncological outcomes and perioperative complications, minimally invasive distal pancreatectomy (MIDP) for pancreatic ductal adenocarcinoma (PDAC) has limited generalizability. The aim of this study was to assess the perioperative and oncologic outcomes of MIDP compared with open distal pancreatectomy (ODP) for resectable PDAC after propensity score matching (PSM). The patients who underwent MIDP and ODP for PDAC between January 2010 and December 2017 were retrospectively r
Like
Comment
Share
